ID26341A - Proses untuk penyediaan dosis yang tetap stabil komposisi zat-zat zat anti infeksi dan mikroorganisme sebagai bahan obat-obatan aktif - Google Patents

Proses untuk penyediaan dosis yang tetap stabil komposisi zat-zat zat anti infeksi dan mikroorganisme sebagai bahan obat-obatan aktif

Info

Publication number
ID26341A
ID26341A IDW991648A ID991648A ID26341A ID 26341 A ID26341 A ID 26341A ID W991648 A IDW991648 A ID W991648A ID 991648 A ID991648 A ID 991648A ID 26341 A ID26341 A ID 26341A
Authority
ID
Indonesia
Prior art keywords
infection
active drug
stable composition
drug materials
providing dosage
Prior art date
Application number
IDW991648A
Other languages
English (en)
Inventor
Bansal Yatish Kumar
Khamar Bakulesh Mafalal
Modi Rajiv Indravadam
Original Assignee
Cadila Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806489.2A external-priority patent/GB9806489D0/en
Application filed by Cadila Pharm Ltd filed Critical Cadila Pharm Ltd
Publication of ID26341A publication Critical patent/ID26341A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IDW991648A 1998-03-27 1998-04-03 Proses untuk penyediaan dosis yang tetap stabil komposisi zat-zat zat anti infeksi dan mikroorganisme sebagai bahan obat-obatan aktif ID26341A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
LK1644598 1998-03-27
GBGB9806489.2A GB9806489D0 (en) 1998-03-27 1998-03-27 The process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent/agents and micro organisms as active ingredients
PCT/IB1998/000445 WO1999049875A1 (en) 1998-03-27 1998-04-03 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients

Publications (1)

Publication Number Publication Date
ID26341A true ID26341A (id) 2000-12-14

Family

ID=26313367

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991648A ID26341A (id) 1998-03-27 1998-04-03 Proses untuk penyediaan dosis yang tetap stabil komposisi zat-zat zat anti infeksi dan mikroorganisme sebagai bahan obat-obatan aktif

Country Status (9)

Country Link
EP (1) EP0998295A1 (id)
JP (1) JP2002516616A (id)
AP (1) AP9901724A0 (id)
AU (1) AU770024B2 (id)
CA (1) CA2291780A1 (id)
EA (1) EA002148B1 (id)
ID (1) ID26341A (id)
UA (1) UA59394C2 (id)
WO (1) WO1999049875A1 (id)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8227235B2 (en) * 2008-12-10 2012-07-24 Alpharma, Llc Compositions and methods for controlling diseases in animals
GB0916335D0 (en) * 2009-09-17 2009-10-28 Martin W J Medicaments
US20130131033A1 (en) * 2010-01-13 2013-05-23 Toyochem Laboratories Pharmaceutical composition for treatment of respiratory tract infections
US11554112B2 (en) 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
TWI908716B (zh) * 2019-02-13 2025-12-21 愛爾蘭商伊泰倫醫療國際有限公司 β-內醯胺化合物及丙磺舒之組合及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8703360L (sv) * 1987-08-31 1989-03-01 Lejus Medical Ab Granulaera produkter (iii)

Also Published As

Publication number Publication date
UA59394C2 (uk) 2003-09-15
AU6415698A (en) 1999-10-18
CA2291780A1 (en) 1999-10-07
AU770024B2 (en) 2004-02-12
EA002148B1 (ru) 2001-12-24
EA199900938A1 (ru) 2000-08-28
EP0998295A1 (en) 2000-05-10
AP9901724A0 (en) 1999-12-31
JP2002516616A (ja) 2002-06-04
WO1999049875A1 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
US4732892A (en) L-α-amino acids as transdermal penetration enhancers
DE69931930D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
EP1233756A4 (en) SOLID EXCIPIENTS FOR IMPROVED ADMINISTRATION OF ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS
DE69531741D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
HUP9801331A3 (en) Tricyclic amide and urea derivatives useful for inhibition of g-protein function and for treatment of proliferative diseases, novel tricyclic amide and urea derivatives, use thereof, pharmaceutical compositions containing these compounds as active ...
MA26563A1 (fr) Composes therapeutiquement actifs contenant de l'indazole en remplacement bio-isosterique du catechol, leur preparation et composition pharmaceutique les contenant
GB2303629B (en) Hydroxamic acids and their use as metalloproteinase inhibitors
FI973828L (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
DE69430132D1 (de) Pernasale zusammensetzung und diese enthaltende pernasale zubereitung
ID26237A (id) Pengantaran zat aktif teraerosolisasi
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
EE04399B1 (et) Spiroasabitsüklilised heterotsüklilised ühendid, nende valmistamise protsess, neid sisaldavad ravimkoostised ja nende kasutamine ravis
BR0009830A (pt) Composições para cuidados com a pele contendo uma combinação de substâncias ativas para cuidados com a pele
DK1069892T3 (da) Fugtighedsaktiverbart terapeutisk system
WO1996026739A1 (en) Use of protealytic enzymes in the treatment of insect bites
PT1017392E (pt) Formulacao de medicamento com libertacao controlada do principio activo
ID26341A (id) Proses untuk penyediaan dosis yang tetap stabil komposisi zat-zat zat anti infeksi dan mikroorganisme sebagai bahan obat-obatan aktif
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
HU905967D0 (en) Process for producing pharmaceutical preparatives containing heterocyclic compounds as active substance and process for producing these new active substances
EP0418341A4 (en) Percutaneous drug delivery system
HUP0401013A3 (en) Active substance combination for medicamentous therapy of nicotine dependency and pharmaceutical composition containing it
IT1301969B1 (it) Sucralfato gel secco granulare e poroso procedimento per la suapreparazione, e composizioni farmaceutiche solide che lo contengono
NO983098D0 (no) Hudheftende farmas°ytisk preparat, spesielt transdermalt terapeutisk system for frigivelse av 17-<beta>-estradiol til den menneskelige organisme
AR002735A1 (es) Formulaciones liquidas de sustancias insecticidas activas.
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения